Quantitative determination of five azole antifungals in human serum by LC-MS/MS and its application to therapeutic drug monitoring

Su-jie ZHANG,He-wei SUN,Jun-jun GUO,Mei CHEN,Xiang-mei YUAN,Shui-jun LI,Xin-hua HU,Yan-yu WANG,Chen YU,Jian-min ZHU
DOI: https://doi.org/10.16155/j.0254-1793.2017.06.16
2017-01-01
Abstract:Objective:To develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS)method for simultaneous determination of five azole antifungals (fluconazole,voriconazole,itraconazole,hydroxitraconazole,posaconazole) in human serum and then to apply it to clinical therapeutic drug monitoring.Methods:The serum samples (50 μL) were precipitated with acetonitrile after the addition of isotope internal standards.The chromatographic separation was performed on XSELECTTM CSHTM C18(2.1 mm × 100 mm,3.5 μm)with the mobile phase of 10 mmol · L-1 ammonium acetate solution (containing 0.1% formic acid)-acetonitrile (containing 0.1% formic acid) at a flow rate of 0.5 mL· min-1.The injection volume was 5 μL and liquid chromatography duration was 5.5 min.The deprotonated ion of analyte was ionized by turbo ion spray and was detected in positive ionization by multiple reaction monitoring mode.Results:The linear concentration ranges of the calibration curves for five azole antifungals were 0.02-20 μg· mL-1.The coefficients of linearity were more than 0.998 6.Withinbatch and between-batch RSD were less than 10.6%.The average recovery ranged from 80.5% to 98.4%.The accuracy ranged from 87.4% to 111.0%.Twenty patients received voriconazole therapy were collected from ICU and hemotology department.Blood concentration of voriconazole ranged from 0.24 μg· mL-1 to 4.06 μg· mL-1.Significant variance was found among patients.Conclusion:The method is suitable for quantitative determination of five azole antifungals in clinical therapeutic drug monitoring practice.
What problem does this paper attempt to address?